Cross Country Healthcare Reports 2025 Results Amid Market Challenges
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cross Country Healthcare ( (CCRN) ) has shared an announcement.
Cross Country Healthcare reported that on March 4, 2026, it released fourth-quarter and full-year 2025 results marked by a 24% year-over-year revenue decline in the quarter to $236.8 million and a 22% drop for the year to $1.05 billion, alongside a sharply wider net loss of $82.9 million in Q4 and $94.9 million for 2025 driven largely by a $77.9 million goodwill and trade name impairment and a $29.6 million deferred tax valuation allowance. Despite continued positive operating cash flow, a strong debt-free balance sheet with about $109 million in cash, share repurchases equivalent to 2.5% of outstanding stock, and broad adoption of its Intellify platform, the company faced a challenging market for travel staffing and disruption from a terminated merger with Aya, even as management signaled a renewed focus on technology-driven growth and cost savings from a 21% U.S. headcount reduction and its India center of excellence.
The most recent analyst rating on (CCRN) stock is a Hold with a $11.00 price target. To see the full list of analyst forecasts on Cross Country Healthcare stock, see the CCRN Stock Forecast page.
Spark’s Take on CCRN Stock
According to Spark, TipRanks’ AI Analyst, CCRN is a Neutral.
The overall stock score is primarily impacted by weak financial performance and bearish technical indicators. The negative P/E ratio and lack of dividend yield further weigh on the valuation. Corporate events provide a mixed outlook, with leadership changes seen positively but the failed merger impacting negatively.
To see Spark’s full report on CCRN stock, click here.
More about Cross Country Healthcare
Cross Country Healthcare, Inc. is a U.S.-based healthcare staffing and workforce solutions provider, supplying nurse and allied professionals as well as physicians to hospitals and other medical facilities. The company increasingly centers its operations on its proprietary Intellify workforce management platform, which now supports most of its managed service and vendor-neutral clients and processes millions of staffing hours annually.
Average Trading Volume: 729,503
Technical Sentiment Signal: Sell
Current Market Cap: $294.2M
See more insights into CCRN stock on TipRanks’ Stock Analysis page.
